CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such ...
While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious ...
Investment in 2025 has reached $9.9 billion, exceeding the $8.4 billion that was raised through the third quarter last year, ...
Implementing artificial intelligence requires significant human labor and technical expertise, threatening to create a ...
Six takeaways from the CMS administrator’s appearance at a D.C. think tank Monday — including who’s set to be the next ...
The FDA cleared AI and imaging updates for Intuitive’s lung biopsy robot. Elsewhere, Horizon completed the first cataract ...
Executives from Stryker and Johnson & Johnson are on the hunt for deals, despite a turbulent environment, they said at ...
Michelle Tarver, director of the Center for Devices and Radiological Health, and other center officials attended virtually as ...
With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...
Capacity at the company's Boston site will increase by 50% as part of a $600 million, 10-year commitment to the U.S.
Boston Scientific also foresees future growth in its Watchman business from a planned label expansion and concomitant ...
The company has now treated 500,000 patients with its pulsed field ablation system, in a competitive category poised for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results